DK410077A - Fremgangsmaade til fremstilling af 9alfa-chlor11-beta-fluor-forbindelser - Google Patents

Fremgangsmaade til fremstilling af 9alfa-chlor11-beta-fluor-forbindelser

Info

Publication number
DK410077A
DK410077A DK410077A DK410077A DK410077A DK 410077 A DK410077 A DK 410077A DK 410077 A DK410077 A DK 410077A DK 410077 A DK410077 A DK 410077A DK 410077 A DK410077 A DK 410077A
Authority
DK
Denmark
Prior art keywords
chlor11
9alfa
beta
preparing
procedure
Prior art date
Application number
DK410077A
Other languages
Danish (da)
English (en)
Inventor
M Biollaz
J Kalvoda
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK410077A publication Critical patent/DK410077A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK410077A 1976-09-16 1977-09-15 Fremgangsmaade til fremstilling af 9alfa-chlor11-beta-fluor-forbindelser DK410077A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU75809A LU75809A1 (fr) 1976-09-16 1976-09-16

Publications (1)

Publication Number Publication Date
DK410077A true DK410077A (da) 1978-03-17

Family

ID=19728351

Family Applications (1)

Application Number Title Priority Date Filing Date
DK410077A DK410077A (da) 1976-09-16 1977-09-15 Fremgangsmaade til fremstilling af 9alfa-chlor11-beta-fluor-forbindelser

Country Status (13)

Country Link
JP (1) JPS5337652A (fr)
AT (1) AT356303B (fr)
AU (1) AU514425B2 (fr)
BE (1) BE858709A (fr)
CA (1) CA1105003A (fr)
DE (1) DE2741067A1 (fr)
DK (1) DK410077A (fr)
FR (1) FR2364928A1 (fr)
GB (1) GB1584826A (fr)
LU (1) LU75809A1 (fr)
NL (1) NL7710086A (fr)
SE (1) SE7710337L (fr)
ZA (1) ZA775537B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3069074D1 (en) 1979-11-16 1984-10-04 Sterosynt Ltd 6-alpha-9-alpha-difluoro-16-beta-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
IT1209140B (it) * 1979-11-16 1989-07-10 Prochem Ets 6 alfa-fluoro-prednisolone 17,21-diesteri.

Also Published As

Publication number Publication date
GB1584826A (en) 1981-02-18
AT356303B (de) 1980-04-25
DE2741067A1 (de) 1978-03-23
SE7710337L (sv) 1978-03-17
JPS5337652A (en) 1978-04-06
LU75809A1 (fr) 1978-05-12
CA1105003A (fr) 1981-07-14
NL7710086A (nl) 1978-03-20
ZA775537B (en) 1978-07-26
AU514425B2 (en) 1981-02-12
FR2364928B1 (fr) 1981-03-06
FR2364928A1 (fr) 1978-04-14
AU2884877A (en) 1979-03-22
BE858709A (fr) 1978-03-15
ATA663077A (de) 1979-09-15

Similar Documents

Publication Publication Date Title
DK13177A (da) Fremgangsmade til fremstilling af phthalaner
DK116177A (da) Fremgangsmade til fremstilling af hentriakontapeptider
DK81277A (da) Fremgangsmade til fremstilling af bis-pyridinium-forbindelser
DK195378A (da) Fremgangsmaade til fremstilling af polyenforbindelser
DK565977A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycinsalte
DK75077A (da) Fremgangsmade til fremstilling af cephemforbindelser
DK147777A (da) Fremgangsmade til fremstilling af acylchromaner
DK147068C (da) Analogifremgangsmaade til fremstilling af 1-naphthylmethyl-cinnamyl-aminderivater
DK148059C (da) Analogifremgangsmaade til fremstilling af anthracyclinglycosidforbindelser
DK164476A (da) Fremgangsmade til fremstilling af piperazinylpyrazinforbindelser
DK144177A (da) Fremgangsmade til fremstilling af acylayanider
DK276177A (da) Fremgangsmade til fremstilling af gammapyron-forbindelser
DK117677A (da) Fremgangsmade til fremstilling af piperidinderivater
DK145877A (da) Fremgangsmade til immoblisering af glucoseisomerase
DK377577A (da) Fremgangsmaade til fremstilling af antiserum
DK123277A (da) Fremgangsmade til fremstilling af 3-halogenmethyl-3-cephem-forbindelser
DK329577A (da) Fremgangsmade til fremstilling af derivater af phenoxyhydroxypropylamin
DK566977A (da) Fremgangsmaade til fremstilling af polyenforbindelser
DK38577A (da) Fremgangsmade til fremstilling af betalactamholdige forbindelser
DK247877A (da) Fremgangsmade til fremstilling af klavamforbindelser
DK97578A (da) Fremgangsmaade til fremstilling af benzylpyrimidin-forbindelser
DK310777A (da) Fremgangsmade til fremstilling af guaiacol-p-isobutyl-hydratropat
DK65877A (da) Fremgangsmaade til fremstilling af mikrokapsler
DK428377A (da) Fremgangsmaade til fremstilling af pyridobenzodiazepinoner
DK156955C (da) Fremgangsmaade til fremstilling af cyanosubstituerede cyclopropanderivater